TRANSPARENCY LIFE SCIENCES
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

TRANSPARENCY LIFE SCIENCES Trademark

Serial Number: 87776246 • Registration: 5707466

TRANSPARENCY LIFE SCIENCES is a trademark filed by Transparency Life Sciences, Inc. on January 30, 2018. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Transparency Life Sciences, Inc. (6 trademarks)

Unit 804
New York, NY 10001

Entity Type: 03

Trademark Details

Filing Date

January 30, 2018

Registration Date

March 26, 2019

Published for Opposition

January 8, 2019

Cancellation Date

October 10, 2025

Goods & Services

Providing online non-downloadable computer software for planning, management and operational management in the field of clinical trials; providing online non-downloadable computer software for crowdsourcing data and information for clinical trials; providing online non-downloadable computer software for collecting, managing, and analyzing data related to crowdsourcing and crowdsharing in the field of clinical trials; providing online non-downloadable computer software for collecting data from clinical trials, for database management in the field of clinical trials; providing online non-downloadable computer software for the management of data from clinical trials; providing online non-downloadable computer software to enable the capture, reporting, and processing of data in pharmaceutical industry clinical trials; providing temporary use of online, non-downloadable, internet-based software for use in clinical trial project management and clinical trial data management; providing online non-downloadable software for planning, managing and operational support of clinical trials; scientific consulting services in the field of conducting clinical trials, and research and development of pharmaceuticals, biopharmaceuticals, and medical devices; clinical research for others in the fields of oncology, cardiology, virology, and infectious disease for the production of pharmaceuticals, biopharmaceuticals, and medical devices, and for the ultimate regulatory approval and registration of the foregoing goods; information technology consulting services relating to the collection, review, analysis and reporting of clinical trial and drug development information; hosting and providing temporary use of online non-downloadable software for use in connection with the collection, review, analysis, and reporting of clinical trial and drug development information; pharmaceutical drug development services; pharmaceutical products development; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Software as a service (SAAS) services featuring software for data management, for electronic storage of data in the field of pharmaceuticals and clinical trials

Filing History

CANCELLED SEC. 8 (6-YR)
Oct 10, 2025 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 26, 2024 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 24, 2019 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 24, 2019 COAR
REGISTERED-PRINCIPAL REGISTER
Mar 26, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 8, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jan 8, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 19, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 27, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 7, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 6, 2018 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 6, 2018 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 24, 2018 GNFN
FINAL REFUSAL E-MAILED
Jul 24, 2018 GNFR
FINAL REFUSAL WRITTEN
Jul 24, 2018 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 7, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 6, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 6, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 17, 2018 GNRN
NON-FINAL ACTION E-MAILED
May 17, 2018 GNRT
NON-FINAL ACTION WRITTEN
May 17, 2018 CNRT
ASSIGNED TO EXAMINER
May 11, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 9, 2018 NWOS